Package Inserts | Oncology & Hematology (N – R)


Nexavar? (sorafenib tablets)
Bayer HealthCare Pharmaceuticals Inc./Onyx Pharmaceuticals, Inc.


Omnitarg? (pertuzumab)


Pemetrexed (Alimta?)
Eli Lilly and Company; Initial U.S. Approval: 2004

Pamidronate disodium (Aredia?)
Novartis Pharmaceuticals Corporation, May 2012

Panretin? (Alitretinoin gel 0.1%)
Ligand Pharmaceuticals Inc.

Q, R

Last Page Update: October 1, 2016

Copyright ? 2017 Sunvalley Communication. All rights reserved. Republication or redistribution of Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of Sunvalley Communication. Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.